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An in vitro assay was used to study the role of ~34~~ in cyclin A-mediated vesicular transport inhibition. It was shown that the S-phase kinase 
p33”dU reduced the effect of cyclin A on transport assays performed with sHeLa cytosol, even though histone kinase was strongly activated. Also, 
transport with FT210 cytosol (which is temperature-sensitive for ~34~‘) was inhibited by cyclin A only at the permissive temperature. However, 
the phosphatase inhibitor microcystin inhibited transport without any requirement for ~34~ activity. These results show that transport is inhibited 
by cyclin A via p340df2, and also by another kinase, possibly downstream of ~34~‘. 
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1. INTRODUCTION 
During mitosis, vesicular transport is inhibited at al- 
most every stage so far examined (reviewed in [l]), in- 
cluding ER-Golgi [2] and intra-Golgi [3] transport, and 
the formation [4] and recycling [5] of endocytic vesicles 
in vivo. In vitro, the fusion of endocytic vesicles is inhib- 
ited, via both cyclin A- and cyclin B-dependent mecha- 
nisms [6,7] . It has also been found in vivo and in vitro 
that both exocytic and endocytic transport are inhibited 
by phosphatase inhibitors, without apparent involve- 
ment of mitotic kinase [&lo]. 
Entry into mitosis requires activation of the key ki- 
nase ~34~” [ll]. The archetypal mitotic kinase MPF 
[ 121 comprises ~34~‘~ and cyclin B, which is synthesised 
and destroyed each cell cycle [13]. This complex is not 
activated until the G2-M boundary, due to regulatory 
phosphorylation (reviewed in [14]), but ~34~“~ also 
forms a complex with cyclin A which is not regulated 
by inhibitory phosphorylation [15]. The cyclin A and B 
complexes with ~34~‘~ have different kinetics of activa- 
tion [16], different locations [17] and probably different 
targets [181 in the cell . While some proteins are known 
to be modified directly by ~34~~ (for example the endo- 
cytic pathway GTP binding protein rab 4 [ 191 or nuclear 
lamins [20,21]), it is not presently clear whether ~34”‘“~ 
acts as a mitotic ‘workhorse’ [22] or as a master control- 
ler activating a variety of downstream pathways. The 
onset of S-phase is controlled, like the onset of mitosis, 
by a cyclin-kinase complex. The major S-phase kinase 
is ~33~ associated with cyclin A [23], and its activity 
is regulated by inhibitory phosphorylation [24]. 
*Corresponding author. Fax: (44) (71) 269-3417. 
We previously studied the mitotic regulation of an in 
vitro assay of intra-Golgi transport. The assay reconsti- 
tutes the vesicle-mediated transport of the vesicular sto- 
matitis virus glycoprotein (VSV-G) between successive 
cisternae of the Goigi stack [25,26]. A Golgi-enriched 
‘donor’ fraction is prepared from a VSV-infected mu- 
tant CHO cell line (clone 15B) which lacks the enzyme 
iV-acetyl-glucosaminyltransferase I (NAGT I) nor- 
mally present in the medial cistemae of the stack, and 
incubated with an ‘acceptor’ Golgi fraction prepared 
from uninfected wild-type cells. G protein transfer from 
the cis compartment of the donor stacks to the NAGT 
I-containing medial cistemae of the acceptor stacks 
leads to incorporation of [3H]GlcNAc (from UDP- 
[3H]GlcNAc) into the G protein. The process requires 
ATP and cytosolic factors which we supplied in sHeLa 
cytosol. The membranes used were ‘KC&washed [27] 
and therefore dependent on the cytosol for provision of 
certain transport components. 
We found that the assay was inhibited by cytosol with 
high mitotic activity (measured as histone kinase activ- 
ity), either isolated from mitotic cells, or generated by 
treatment of interphase cytosol with cyclin A [28]. 
Transport inhibition was dependent on kinase activa- 
tion, since it could be blocked by the kinase inhibitor 
staurosporine. It was not possible, however, to prove 
that ~34~~, rather than ~33~, was responsible for the 
transport inhibition. 
This paper addresses this problem using recombinant 
p33*=, and cytosol from a cell line with a temperature- 
sensitive mutation in ~34~‘. The results con8rrn that 
cdc2 the mitotic p34 kinase is the direct target of cyclin A 
in transport inhibition. It also demonstrates that trans- 
port can be inhibited by a non-histone kinase, perhaps 
one downstream of the mitotic kinase. 
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2. MATERIALS AND METHODS 3. RESULTS 
2.1. Materials 
Cyclin A and ~33~” were prepared from bacterial ysates (as de- 
scribed in [28,29]). Cell culture media were bought from Gibco BRL, 
with the exception of RPMI, which was made in-house. Microcystin 
and staurosporine were purchased from Calbiochem. Borosilicate 
glass assay tubes were obtained from Samco, and [‘I-IjUDP-N-ace- 
tylglucosamine from New England Nuclear. Monoclonal anti-VW-G 
antibody was affinity-purified from the culture supernatant of the 8G5 
cell line, a kind gift of Drs. Lefrancois and Lyles [30]. Polyclonal rabbit 
anti-mouse IgG was purchased from Dakopatts. Glassfibre filters 934- 
AH and P81 paper were obtained from Whatman. [Y-‘~P]ATP was 
purchased from Amersham. 
2.2. Cells 
The CHO, 15B CHO and suspension HeLa cells were maintained 
as described in [28]. FM3A and FT210 cells were maintained at 32°C 
in RPM1 with 2% bicarbonate, supplemented with 10% foetal calf 
serum, 200 mM glutamine, 1% penicillin/streptomycin and 1% non- 
essential amino acids. 
3.1. The effect of the S-phase kinase, ~33’~, on the 
transport assay 
p33”dk2 is closely related to ~34~“~. It requires associ- 
ation with a cyclin for its activity and, while ~34~’ is 
associated with cyclins A and B in vivo, ~33~~ is asso- 
ciated with cyclins A, C, D and E [24,32,33]. Therefore, 
exogenous p33 cdk2 should be capable of competing with 
endogenous ~34~‘~ for cyclin A, but would not be ex- 
pected to mediate in vitro transport inhibition. 
sHeLa cytosol was treated with cyclin A in the pres- 
ence or absence of 1 ,ug p33”dk2, and then tested for both 
histone kinase activity and support of the transport 
reaction (Fig. 1). 
Fig. la 
2.3. Cytosols and membranes 
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All membranes used in the work in this paper were prepared as in 
[28]. Golgi fractions were salt-washed as described [271 except that 
they were washed in a final concentration of 1 M KC1 for 10 min on 
ice. sHeLa cytosol was prepared as described, and FM3A and FT210 
cytosols were prepared in the same way, using -1 x lo9 cells per prepa- 
ration. 
2000- 
2.4. Transport assays 
Transport assays were performed basically as in Balch [25], with 
modifications for the pretreatment of cytosol and the use of salt- 
washed Golgi. For assays using sHeLa cytosol, assay premixtures 
were prepared containing transport buffer and ATP-regenerating sys- 
tem (25 mM HEPES-KOH, pH 7.0, 25 mM KCl, 2.5 mM MgOAc, 
1 mM DTT, 4 PM palmitoyl coenzyme A, 1 mM ATP, 1 mM UTP, 
2 mM creatine phosphate, lo&ml rabbit muscle creatine kinase) and 
exogenous proteins or equivalent buffers as appropriate. Cytosol(50 
pg) was added to this and the whole preincubated for 20 min at 37’C. 
Then the reactions were removed to ice, and the salt-washed mem- 
branes added. The reactions were incubated for 10 min at room tem- 
perature, and then at 3O’C for 2 h. During the first 30 min of the 
transport reactions, 2 ~1 samples were withdrawn for histone kinase 
assay of the cytosol. 
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Fig. Zb 
For assays using cytosols from the murine cell lines FM3A and 
FT210, premixtures were made containing transport buffer and ATP- 
regenerating system. The cytosol (20 pug) was added to this, and the 
mixture was preincubated for 20 min at either 32°C or 39°C. Then, 
on ice, recombinant cyclin A or drugs (or equivalent buffer) were 
added, and this mixture was incubated for 20 min at 32°C. Then the 
reactions were removed to ice, and the salt-washed membranes added. 
The assays were incubated for 10 min at room temperature, and then 
at 30°C for 2 h. During the first 30 min of the transport reactions, 5 ~1 
samples were withdrawn for histone kinase assay of the cytosol. 
histone kinase 
activity 
(nmoumin/ 
mg protein) 
Histone kinase assays were according to Felix et al. [31]. For sHeLa 
cytosol, 2 jfl aliquots (containing -2 pg cytosol) were removed from 
transport assays during the first 30 min of the transport reaction, and 
assayed for 10 min at 37°C in the presence of histones and [Y-‘~P]ATP. 
For mouse cytosols, 5 ~1 samples (containing -2 pg cytosol) were 
assayed for 20 min at 32’C. Under these conditions, the calculated 
specific activity of sHeLa cytosol did not markedly differ from that 
at 37°C. 
In all cases, the results shown are typical examples of assays per- 
formed under the conditions described with various preparations of 
membranes and cytosol. 
Fig. 1. Reduction in cyclin A-mediated transport inhibition by ~33’~“. 
Recombinant cyclin A was added to the sHeLa cytosol(50 fig) prein- 
cubation in varying quantities (or an equivalent of buffer). The titra- 
tion was performed in the absence (open squares) or presence (closed 
squares) of 1 pg of p33cdk2. Transport and histone kinase assays were 
performed as described in section 2. (a) Shows the resultant ransport 
activity and (b) shows the histone kinase activity of the cytosols. 
550 
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In the absence of cyclin A, ~33~” had no effect on bation at both 32°C and 39°C (Figs. 3a,b). In contrast, 
transport, or occasionally increased the transport signal FT210 cytosol supported transport inhibition after in- 
while, in the presence of cyclin A, ~33~~’ apparently cubation at 32”C, but could not be inhibited by cyclin 
reduced the level of cyclin available for transport inhibi- A after 39°C incubation (Fig. 3~). Likewise, cyclin A 
tion (Fig. la). The histone kinase activity of the cytosol caused histone kinase activation after treatment at the 
was consistently elevated in the presence of ~33~~ (Fig. permissive, but not the restrictive temperature (Fig. 3d). 
lb). Therefore, elevation of histone kinase activity This showed that functional ~34~~ was required for 
could not in itself be responsible for inhibition of the cyclin A-mediated histone kinase activation and trans- 
transport assay by cyclin A. port inhibition. 
To see whether the effect of ~33~’ was linked with 
its level in the assay, the protein was titrated into trans- 
port assays in the presence of a fixed quantity (1 pug) of 
cyclin A. Fig. 2 shows that the level of transport was 
increased by increasing levels of ~33~~, though histone 
kinase activity was concurrently elevated to a high level. 
It should be noted that, in the absence of cyclin A, 
P33 cdk;? for the most part had no effect on the transport 
or the histone kinase activity of the cytosol, which sug- 
gests that very little of the endogenous cyclin in the 
cytosol was capable of activating the exogenous kinase. 
3.3. Effect of microcystin on FT210 cytosol 
3.2. Ablation of p34cdc2in the FT210 cell line 
Experiments were performed with cytosol isolated 
from the murine cell line FT210. This line, a derivative 
of FM3A, is temperature-sensitive for ~34~‘~ [34,35]. It 
behaves like the parental line at 32°C but at 39°C its 
~34~“~ protein is inactivated, and the cells become inca- 
pable of undergoing mitosis. Cytosol was isolated from 
these cells in exactly the same way as from sHeLa cells, 
and supported transport with considerably higher spe- 
cific activity than sHeLa preparations. An experiment 
was performed in which the mouse cytosols were pre- 
treated at either permissive or restrictive temperatures, 
and then treated with cyclin A. The effect of this treat- 
ment is shown in Fig. 3. 
It was notable that transport inhibition required a 
much smaller elevation of histone kinase activity in 
FT210 cytosol than in sHeLa cytosol (compare Figs. 1 
and 3). It had been observed that okadaic acid and 
microcystin, inhibitors of phosphatases-1 and -2A 
[36,37] were incapable of activating sHeLa cytosol or 
inhibiting transport under transport conditions ([28] 
and DM unpublished data). When microcystin was 
added to FT210 cytosol, transport was inhibited (Fig. 
4a). At the same time, the histone kinase activity of the 
cytosol was elevated, though about 50% less than it 
would be for similar transport inhibition by cyclin A 
(data not shown). The effect of microcystin was the 
same after both 32°C and 39°C preincubations, which 
showed that the effect did not require activity of ~34~“. 
However, the effect did require kinase activity, since 
simultaneous addition of microcystin and staurosporine 
(a general kinase inhibitor; see [38]) to cytosol com- 
pletely blocked transport inhibition and the small eleva- 
tion of histone kinase activity (Fig. 4b and data not 
shown). Okadaic acid had very similar effects upon 
transport (data not shown). 
Cyclin A caused transport inhibition with elevation 
of histone kinase activity in FM3A cytosol, after incu- 
4. DISCUSSION 
~33~” alleviated the cyclin A-dependent inhibition of 
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Fig. 2. Titration of ~33~~~ into a transport assay in presence of a fixed quantity (1 pg) of recombinant cyclin A. Cytosols were preincubated with 
cyclin A and different levels of ~33~“, and then assayed for transport (solid line) and histone kinase (dashed line) activities. 
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Fig. 3. Effect of cyclin A on FM3A and FT210 cytosols. Cytosol(20 pug) was preincubated in transport buffer for 20 min at 32°C or 39’C. The 
reactions were removed to ice and treated with either cyclin A (2.5 rg} or equivalent buffer, then incubated for 20 mm at 32°C. After this, transport 
and histone kinase activities were assayed. (a> and (c) Show transport activities and (b) and (d) histone kinase activities. 
the transport assay. This result indicated that histone 
kinase activity was not in itself sufficient for transport 
inhibition, but that the active kinase is one which com- 
petes with ~33~ for cyclin A. Since ~34~’ and ~33”~~ 
are the only kinases known to associate with cyclin A 
[23], ~34~” was by implication the target of cyclin A in 
inhibition of the assay. 
It has not been possible to test the effect of ~34~‘~ 
directly in the assay, since recombinant ~34~~ has not 
yet been successfully activated, nor purified active 
p34*2 made available in sufficient quantities to influ- 
ence the sHeLa system in our hands (D.M., unpublished 
data}. This presumably reflects the fact that ~34~” com- 
plexed with cyclin B is subject to stringent phosphoryl- 
ation control [39], whereas the level of cyclin A-depend- 
552 
ent ~34~” kinase activity is proportional to the level of 
cychn A during the cell cycle [15]. The cyclin A-p3Ydk2 
complex is apparently phospho~lat~ during G 1 in the 
same way as the cyclin B-~34~‘~ complex during inter- 
phase [24], but it may well be that the general phospho- 
rylation condition of the cytosol preparations used in 
this work is conducive to activation of an S-phase ki- 
nase, but not an M-phase kinase. 
The role of ~34~~ was supported by the effect of its 
ablation on the transport assay in FT210 cytosol. In the 
absence of ~34~“‘, cyclin A had no effect on the trans- 
port or the histone kinase activity of the mutant cytosol. 
Cyclin A caused a maximum of 24-fold elevation of 
histone kinase activity, thus inhibition of the transport 
assay requires lower histone kinase activity in ET210 
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Fig. 4. Effect of the phosphatase inhibitor ~~~ystjn on FM3A and 
FT210 cytosols. Cytosol was preincubated in transport bufIer for 20 
min at either 32°C or 39°C. The assays were next preincubated for 20 
min at 32°C with or without 1 PM microcystin and staurosporine, and 
then (a) transport and (b) histone kinase activities were assayed. 
cytosol than in sHeLa cytosol. This difference between 
the cell lines may reflect a difference in their levels of 
p34&2 or its accessory proteins. 
Transport in the presence of FT210 cytosol was in- 
hibited by microcystin, an inhibitor of phosphatases-1 
and -2A, while histone kinase activity was not signifi- 
cantly elevated. This showed that transport could be 
regulated by another, non-histone kinase either down- 
stream of p34*” or independent of it. Staurosporine 
had no direct effect on transport, but could block micro- 
cystin-mediated inhibition. This indicated that micro- 
cystin was not altering activity of a kinase required for 
interphase transport, but rather causing activation of a 
kinase capable of inhibiting it. 
Phosphatase inhibitors appear to act on vertebrate 
systems on two levels. Okadaic acid has been shown to 
cause maturation of Xenopus oocytes [40] and activa- 
tion of oocyte extracts [41], and pseudo~toti~ effects 
with histone kinase activation of BHK cells [42]. It has 
been shown to cause activation of ~34~“’ by blocking 
inhibition of the cdc25 phosphatase [43] or by promot- 
ing inactivation of wee1 kinase [44]. However, in HeLa 
cells okadaic acid inhibits transport and causes pseu- 
domitotic Golgi vesiculation without elevation of his- 
tone kinase activity [8]. Likewise, in vitro exocytic [9] 
and endocytic [lo] assays were inhibited by okadaic acid 
and microcystin, via inhibition of PP2A, without in- 
volvement of p34 0dc2. It has been suggested that Xenopus 
oocytes and hamster cell lines differ from the okadaic 
acid-refractory systems in cell-cycle controls; also, Xen- 
opus oocytes possess tored cyclins, and BHK cells are 
able to manufacture them under cell-cycle blocks, 
whereas human cell lines did not accumulate cyclin B 
[45]. Nevertheless, cell lines not advanced into mitosis 
by okadaic acid may possess other kinases susceptible 
to intervention by phosphatase inhibitors. 
It appears that, while high mitotic kinase activity is 
responsible for the inhibition of intra-Golgi transport, 
p34&cZ might not act directly on the system, but rather 
use an intermediate kinase. Since this appears to be the 
case in a number of other transport assay systems, it is 
possible that a single kinase mechanism will be found 
to be responsible for inhibition of all these vesicular 
transport events. 
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